Clinical Trials on SARS-Associated Coronavirus

Total 10386 results

Ascletis Pharmaceuticals Co., Ltd.

Not yet recruiting

Study to Evaluate Safety, Tolerability, Efficacy and Pharmacokinetics of ASC10 in Mild to Moderate COVID-19 Patients

SARS CoV 2 Infection

United States
International Vaccine Institute
Heidelberg University; International Centre for Diarrhoeal Disease Research... and other collaborators

Recruiting

Effectiveness Evaluation of the Sinopharm Vaccine in the Dondo District in Mozambique

Sars-CoV-2 Infection

Mozambique
Colorado School of Public Health
University of Colorado, Denver; University of Colorado, Boulder; Colorado State... and other collaborators

Recruiting

Asymptomatic and Pre-symptomatic Transmission of SARS-CoV-2 in a Community Congregant Setting

COVID-19 | SARS-CoV2 Infection

United States
Assistance Publique - Hôpitaux de Paris

Recruiting

LIPId Profile Changes in Inflammatory Conditions Induced by SARS-CORoronavirus-2 (LIPICOR)

SARS-CoV2 Infection

France
Beijing 302 Hospital

Not yet recruiting

A Trial of Novaferon in Asymptomatic or Mild COVID-19 Patients

SARS-CoV2 Infection
Jens D Lundgren, MD
Ministry of the Interior and Health, Denmark

Completed

A Phase IV Vaccine Study Under the National Cohort Study of Effectiveness and Safety of SARS-CoV-2 (COVID-19) Vaccines.

SARS CoV 2 Infection

Denmark
Barcelona Institute for Global Health
Hospital del Mar; Hospital Universitario Infanta Leonor; Eduardo Mondlane University and other collaborators

Active, not recruiting

SARS-CoV-2 and Acetylsalicylic Acid (SARA) (SARA)

Covid19 | SARS-CoV2 Infection

Spain, Mozambique
Hipra Scientific, S.L.U
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta; Fundación FLS... and other collaborators

Completed

A Phase III Clinical Trial to Assess Safety and Immunogenicity of a COVID-19 Vaccine Booster Dose in Immunosupressed Adults.

SARS CoV 2 Infection

Spain, Turkey
Dompé Farmaceutici S.p.A

Completed

Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.

SARS CoV 2 Infection

France, Spain, Italy
Rutgers, The State University of New Jersey
National Institute of Dental and Craniofacial Research (NIDCR)

Completed

Rutgers Pilot for PREDICT- Patient LAB Test

SARS-CoV2 Infection

United States
The Hospital for Sick Children

Completed

The School SPIT Study - Elementary Schools in Low COVID-19 Incidence Regions

SARS-CoV2 Infection

Canada
Collegium Medicum w Bydgoszczy

Completed

Impact of PCSK9 Inhibition on Clinical Outcome in Patients During the Inflammatory Stage of the COVID-19 (IMPACT-SIRIO 5)

Sars-CoV-2 Infection

Poland
Sona Nanotech Inc
Nova Scotia Health Authority

Completed

Clinical Evaluation of the SONA Saliva C-19 Rapid Self-Test for the Detection of COVID-19

Sars-CoV-2 Infection

Canada
IRCCS Sacro Cuore Don Calabria di Negrar

Active, not recruiting

Viral Load Analysis of the SARS-CoV-2 Virus in Nose Versus Mouth Sites

Sars-CoV-2 Infection

Italy
Chinese University of Hong Kong

Terminated

Novel SARS-CoV-2 Point-of-care Testing

SARS-CoV2 Infection

Hong Kong
AIDAR Health, Inc.
MAXIS, LLC

Withdrawn

AIDI - Research & Development of a Multisensor-Based Machine Learning Technology for Real-Time Automated Detection of COVID-19 Decompensation (AIDI)

Sars-CoV-2 Infection

United States
Larissa University Hospital

Completed

Effect of Nasopharyngeal Wash With Normal Saline on SARS-CoV2 Viral Load

SARS-CoV2 Infection

Greece
Enanta Pharmaceuticals, Inc

Completed

A Study of EDP-235 in Healthy Subjects

SARS CoV 2 Infection

United States
MiCo BioMed Co., Ltd.
Syntactx

Completed

TekiTrust Tests to Determine the Level of SARS-COV-2/COVID-19 Neutralizing Antibodies in the Blood

SARS-CoV2 Infection

United States
Hôpital Universitaire Sahloul

Completed

Nigella 5 in the Treatment of SARS COV2 (COVID-19) (Nigelle5)

SARS-CoV2 Infection

Tunisia
PT Bio Farma
Sinovac Life Sciences Co., Ltd.; Faculty of Medicine Universitas Padjadjaran; National Intitute of Health Research and Development, Ministry of Health Republic of Indonesia

Completed

Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine (COVID-19)

SARS-CoV2 Infection

Indonesia
HyperSpectral APD

Suspended

Validation of HyperDetector for SARS-CoV-2

SARS-COV2 Infection

United States
University Hospital, Montpellier

Withdrawn

Risk of SARS-CoV-2 Infection (COVID-19) in a Standing Concert in a Closed Performance Hall (ConcerTest)

SARS-CoV-2
Adaptive Biotechnologies

Withdrawn

ImmuneSense™ COVID-19 Cross-Reactivity Study

SARS-CoV-2 Infection | Coronavirus Disease

United States
Saint Francis Care

Completed

Convalescent Plasma in the Treatment of COVID 19

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | COVID | Coronavirus

United States
Bayer
CureVac

Withdrawn

COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older (CV-NCOV-011)

Coronavirus Disease 2019 (COVID-19) | SARS-CoV-2 Infection
Imunon

Recruiting

Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2

SARS CoV 2 Infection

United States
Cancer Institute and Hospital, Chinese Academy...
Yunnan Center for Disease Control and Prevention

Recruiting

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above

SARS-CoV2 Infection

China
University Hospital, Brest

Recruiting

Evaluation of the Sofia SARS Antigen FIA Assay for COVID-19 (ESADEC)

SARS-CoV2 Infection

France
Medical University Innsbruck
Medical University of Graz; Medical University of Vienna

Recruiting

Heterologous SARS-CoV-2 Vaccination With ChAdOx-1 and BNT162b2 (HeVacc)

SARS-CoV2 Infection

Austria
Imperial College London

Withdrawn

Recovering From COVID-19 (OVER-COVID)

SARS CoV 2 Infection
Michigan State University
Johns Hopkins University; National Cancer Institute (NCI)

Active, not recruiting

Rural Tailored COVID-19 Communication to Promote SARS-CoV-2 Antibody Testing in Saliva

SARS-CoV2 Infection

United States
Barcelona Institute for Global Health
Centro de Investigação em Saúde de Manhiça; Centre de Recherche Médicale de... and other collaborators

Active, not recruiting

Prevalence and Impact of COVID-19 on Maternal and Infant Health in African Populations (MA-CoV)

COVID-19 | SARS-CoV2 Infection

Gabon, Mozambique
Alvea Holdings, LLC

Completed

Safety, Tolerability and Immunogenicity of Alveavax-v1.2, a BA.2/Omicron-optimized, DNA Vaccine for COVID-19 Prevention

Sars-CoV-2 Infection

South Africa
Murdoch Childrens Research Institute
Rhinomed Pty Ltd

Completed

Diagnosis of Respiratory Viruses in Children With Rhinoswab Junior

COVID-19 | SARS CoV 2 Infection

Australia
HDT Bio
Kaiser Permanente; Rainier Clinical Research Center; C3 Research Associates

Active, not recruiting

Safety And Immunogenicity Of HDT-301 Targeting A SARS-CoV-2 Variant Spike Protein

SARS-CoV2 Infection

United States
Bharat Biotech International Limited

Completed

COVAXIN in a Pediatric Cohort (COVAXIN-Peds)

SARS-CoV2 Infection

India
First Affiliated Hospital Xi'an Jiaotong University

Completed

Effectiveness of COVID-19 Vaccines Against the SARS-COV-2 Delta (B.1.617.2) (FASTER)

SARS CoV 2 Infection

China
Centre Hospitalier Universitaire Saint Pierre

Completed

Coronavirus Pediatric Serological Study (CoPSS)

SARS-CoV2 Infection

Belgium
Medecins Sans Frontieres, Spain
International Centre for Diarrhoeal Disease Research, Bangladesh; Foundation... and other collaborators

Unknown

Prognostication of Oxygen Requirement in Non-severe SARS-CoV-2 Infection (PRIORITISE)

COVID | SARS-CoV2

Brazil, India
Memorial Sloan Kettering Cancer Center

Withdrawn

A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19

COVID-19 | COVID19 | Sars-CoV2 | SARS-Cov-2

United States
Heidelberg University

Unknown

Risk Prediction and Therapy Monitoring in Patients With SARS-Cov-2 Infection / COVID 19 (CROWNLESS)

COVID | SARS-CoV2

Germany
Centre Leon Berard

Completed

Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection (ONCOVID-19)

Cancer | Sars-CoV2

France
Invivoscribe, Inc.

Unknown

The Use of Peripheral Blood Specimens From Patients Suspected of Having SARS-CoV-2 Infections in Research Studies Intended to Support the Development of COVID-19 Detection Methods, Treatments, and/or Vaccines

SARS-CoV-2
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Completed

Incidence of VAP in Patients With Severe COVID-19 (CoV-AP)

Covid19 | Ventilator Associated Pneumonia

Italy
AUVA
Paracelsus Medical University

Completed

Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel.

Coronavirus Infection | SARS-CoV 2 | Covid19 | Severe Acute Respiratory Syndrome Coronavirus 2

Austria
NYU Langone Health
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Understanding the Long-term Impact of COVID-19 in Adults (RECOVER)

SARS-CoV2 Infection

United States, Puerto Rico
University Hospital, Limoges

Recruiting

Remote Assessment of Outpatient With Severe Acute Respiratory Syndrome (SARS-CoV-2) (EVIDENCE)

SARS-CoV2 Infection

France
BioNTech SE
Pfizer

Completed

Study to Evaluate Safety, Tolerability & Immunogenicity of BNT162b2 in Immunocompromised Participants ≥2 Years

SARS-CoV-2 Infection, COVID19

United States, Brazil, Germany, Mexico
Sophia Koo, M.D.
Massachusetts General Hospital; GlaxoSmithKline; Dana-Farber Cancer Institute

Active, not recruiting

A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals

SARS CoV 2 Infection

United States

Clinical Trials on SARS-Associated Coronavirus

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations